| Adipose tissue as an endocrine organ S Galic, JS Oakhill, GR Steinberg Molecular and cellular endocrinology 316 (2), 129-139, 2010 | 2481 | 2010 |
| AMPK in health and disease GR Steinberg, BE Kemp Physiological reviews 89 (3), 1025-1078, 2009 | 1869 | 2009 |
| Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase AL Carey, GR Steinberg, SL Macaulay, WG Thomas, AG Holmes, ... Diabetes 55 (10), 2688-2697, 2006 | 1045 | 2006 |
| Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin MD Fullerton, S Galic, K Marcinko, S Sikkema, T Pulinilkunnil, ZP Chen, ... Nature medicine 19 (12), 1649-1654, 2013 | 892 | 2013 |
| The ancient drug salicylate directly activates AMP-activated protein kinase SA Hawley, MD Fullerton, FA Ross, JD Schertzer, C Chevtzoff, KJ Walker, ... Science 336 (6083), 918-922, 2012 | 816 | 2012 |
| Energy-stress-mediated AMPK activation inhibits ferroptosis H Lee, F Zandkarimi, Y Zhang, JK Meena, J Kim, L Zhuang, S Tyagi, L Ma, ... Nature cell biology 22 (2), 225-234, 2020 | 693 | 2020 |
| AMPK as a therapeutic target for treating metabolic diseases EA Day, RJ Ford, GR Steinberg Trends in Endocrinology & Metabolism 28 (8), 545-560, 2017 | 533 | 2017 |
| AMP-activated protein kinase: the current landscape for drug development GR Steinberg, D Carling Nature reviews Drug discovery 18 (7), 527-551, 2019 | 522 | 2019 |
| Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling GR Steinberg, BJ Michell, BJW van Denderen, MJ Watt, AL Carey, ... Cell metabolism 4 (6), 465-474, 2006 | 519 | 2006 |
| Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36 A Bonen, ML Parolin, GR Steinberg, J Calles‐Escandon, NN Tandon, ... The FASEB Journal 18 (10), 1144-1146, 2004 | 506 | 2004 |
| AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity HM O’Neill, GP Holloway, GR Steinberg Molecular and cellular endocrinology 366 (2), 135-151, 2013 | 491 | 2013 |
| Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis JD Crane, R Palanivel, EP Mottillo, AL Bujak, H Wang, RJ Ford, A Collins, ... Nature medicine 21 (2), 166-172, 2015 | 490 | 2015 |
| AMP-activated protein kinase (AMPK) β1β2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise HM O'Neill, SJ Maarbjerg, JD Crane, J Jeppesen, SB Jørgensen, ... Proceedings of the National Academy of Sciences 108 (38), 16092-16097, 2011 | 481 | 2011 |
| High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus BG Drew, SJ Duffy, MF Formosa, AK Natoli, DC Henstridge, SA Penfold, ... Circulation 119 (15), 2103-2111, 2009 | 472 | 2009 |
| Treatment of nonalcoholic fatty liver disease: role of AMPK BK Smith, K Marcinko, EM Desjardins, JS Lally, RJ Ford, GR Steinberg American Journal of Physiology-Endocrinology and Metabolism 311 (4), E730-E740, 2016 | 447 | 2016 |
| Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro EW Petersen, AL Carey, M Sacchetti, GR Steinberg, SL Macaulay, ... American Journal of Physiology-Endocrinology and Metabolism 288 (1), E155-E162, 2005 | 400 | 2005 |
| Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis SL Pinkosky, RS Newton, EA Day, RJ Ford, S Lhotak, RC Austin, ... Nature Communications 7 (1), 13457, 2016 | 396 | 2016 |
| MicroRNA-33–dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis M Ouimet, HN Ediriweera, UM Gundra, FJ Sheedy, B Ramkhelawon, ... The Journal of clinical investigation 125 (12), 4334-4348, 2015 | 368 | 2015 |
| Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity S Galic, MD Fullerton, JD Schertzer, S Sikkema, K Marcinko, CR Walkley, ... The Journal of clinical investigation 121 (12), 4903-4915, 2011 | 367 | 2011 |
| The Na+/glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels SA Hawley, RJ Ford, BK Smith, GJ Gowans, SJ Mancini, RD Pitt, EA Day, ... Diabetes 65 (9), 2784-2794, 2016 | 323 | 2016 |
